Evaluation of semen variables, sperm chromosomal abnormalities and reproductive endocrine profile in patients with chronic hepatitis C
- 16 December 2009
- journal article
- Published by Wiley in BJU International
- Vol. 105 (1) , 79-86
Abstract
Study Type – Aetiology (case series) Level of Evidence 4 OBJECTIVE: To evaluate reproductive endocrine profile, sperm chromosomal abnormalities, and semen quality in patients with chronic hepatitis C. PATIENTS, SUBJECTS AND METHODS: In all, 82 patients with chronic hepatitis C, aged 18–60 years, were recruited for the study; 76 age‐matched healthy male volunteers served as controls. All participants provided a medical history and had a complete physical examination and routine semen analysis. Two blood samples were drawn from each participant at 15‐min intervals to determine the resting levels of luteinizing‐hormone (LH), follicle‐stimulating hormone (FSH), prolactin, testosterone, oestradiol, and sex hormone‐binding globulin. The hypothalamus‐pituitary‐testis axis was assessed using the gonadotrophin‐releasing hormone (GnRH) test. All participants also received an injection of human chorionic gonadotrophin (hCG) and serum testosterone was determined before the hCG injection and on the third day afterwards. Conventional karyotype analysis and triple‐colour fluorescence in situ hybridization for chromosomes X, Y and 18 were conducted in all patients and controls. RESULTS: The mean basal serum levels for LH, FSH, and testosterone in patients with hepatitis C was significantly lower than the mean for normal controls ( P = 0.01). The injection of GnRH analogue did not yield significantly higher FSH and LH levels in the patients than in normal controls ( P = 0.001). In patients with chronic hepatitis C, the mean total sperm count, motility and normal morphology was significantly lower than in controls ( P = 0.001). There was a significantly greater frequency of disomy in men with chronic hepatitis C than controls for chromosomes 18, X, and Y ( P = 0.01). CONCLUSIONS: Patients with chronic hepatitis C are at risk of showing sperm chromosomal abnormalities, the incidence of which is higher in patients with more advanced disease. Hypogonadotrophic hypogonadism is caused by the selective loss of pituitary gonadotrophin function. Further studies are needed to replicate our results.Keywords
This publication has 34 references indexed in Scilit:
- Ribavirin and pegylated interferon treatment for hepatitis C was associated not only with semen alterations but also with sperm deoxyribonucleic acid fragmentation in humansFertility and Sterility, 2009
- Evaluation of Endocrine Profile, Hypothalamic–Pituitary–Testis Axis and Semen Quality in Multiple SclerosisJournal of Neuroendocrinology, 2008
- Sperm ultrastructure and meiotic segregation in a group of patients with chronic hepatitis B and CAndrologia, 2008
- The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwideJournal of Hepatology, 2006
- Overexpression of Hepatitis C Virus NS5A Protein Induces Chromosome Instability via Mitotic Cell Cycle DysregulationJournal of Molecular Biology, 2006
- Human male infertility: chromosome anomalies, meiotic disorders, abnormal spermatozoa and recurrent abortionHuman Reproduction Update, 2000
- Aneuploidy frequencies in semen fractions from ten oligoasthenoteratozoospermic patients donating sperm for intracytoplasmic sperm injectionFertility and Sterility, 1999
- An Algorithm for the Grading of Activity in Chronic Hepatitis CHepatology, 1996
- Effect of liver transplantation on sex-hormone disorders in male patients with alcohol-induced or post-viral hepatitis advanced liver diseaseJournal of Hepatology, 1994
- Comparison of methods for determination of testosterone and non-protein bound testosterone in men with alcoholic liver diseaseScandinavian Journal of Clinical and Laboratory Investigation, 1986